Publisher
Springer Berlin Heidelberg
Reference28 articles.
1. Abt D, Hechelhammer L, Müllhaupt G, Markart S, Güsewell S, Kessler TM, Schmid H-P, Engeler DS, Mordasini L (2018) Comparison of Prostatic Artery Embolisation (PAE) versus Transurethral Resection of the Prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ 361:k2338
2. Abt D, Müllhaupt G, Hechelhammer L, Markart S, Güsewell S, Schmid H-P, Mordasini L, Engeler DS (2021) Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2-yr outcomes of a randomised, open-label single-centre trial. Eur Urol 80(1):34–42
3. Amparore D, Fiori C, Valerio M, Schulman C, Giannakis I, De Cillis S, Kadner G, Porpiglia F (2021) 3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction. Prostate Cancer Prostatic Dis 24(2):349–357
4. Chughtai B, Elterman D. Shore N, Gittleman M, Motola J, Pike S, Hermann C, Terrens W, Kohan A, Gonzalez RR, Katz A, Schiff J, Goldfischer E, Grunberger I, Tu LM, Alshak MN, Kaminetzky J (2020) The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled Trial Urology 153:270–276. https://doi.org/10.1016/j.urology.2020.12.022. Epub 2020 Dec 26. PMID: 33373708
5. Darson MF, Alexander EE, Schiffman ZJ, Lewitton M, Light RA, Sutton MA, Delgado-Rodriguez C, Gonzalez RR (2017) Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezūm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Res Rep Urol 9:159–168